Deborah Schnell - Net Worth and Insider Trading

Deborah Schnell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deborah Schnell owns 1 companies in total, including Interpace Biosciences Inc (IDXG) .

Click here to see the complete history of Deborah Schnell’s form 4 insider trades.

Insider Ownership Summary of Deborah Schnell

Ticker Comapny Transaction Date Type of Owner
IDXG Interpace Biosciences Inc 2004-03-10 EVP Business Development

Deborah Schnell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deborah Schnell Ownership Network

Ownership Network List of Deborah Schnell

No Data

Ownership Network Relation of Deborah Schnell

Insider Network Chart

Deborah Schnell Owned Company Details

What does Interpace Biosciences Inc do?

Who are the key executives at Interpace Biosciences Inc?

Deborah Schnell is the EVP Business Development of Interpace Biosciences Inc. Other key executives at Interpace Biosciences Inc include Principal Financial Officer Christopher Mccarthy , director & President and CEO Thomas W. Burnell , and 10 percent owner Peter H Kamin .

Interpace Biosciences Inc (IDXG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interpace Biosciences Inc (IDXG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interpace Biosciences Inc (IDXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interpace Biosciences Inc (IDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Interpace Biosciences Inc Insider Transactions

No Available Data

Deborah Schnell Mailing Address

Above is the net worth, insider trading, and ownership report for Deborah Schnell. You might contact Deborah Schnell via mailing address: C/o Pdi Inc, 10 Mountainview Rd, Upper Saddle River Nj 07458.

Discussions on Deborah Schnell

No discussions yet.